Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Transdiagnostic therapies in primary care

Hans Duvefelt, MD
Conditions
October 30, 2018
Share
Tweet
Share

I learned a new word recently: transdiagnostic, which refers to something that is applicable across a spectrum of conditions. It seems that this is becoming an increasingly popular concept in treating anxiety disorders.

No wonder. As I researched this word, I read this:

As of 2013, there are twelve anxiety-disorder diagnoses and over twenty-five subtypes and categories of these disorders, with specific treatments for about half of them. Research has demonstrated that these treatments, particularly cognitive behavioral ones, help most people recover from anxiety disorders. Over the last few years, however, researchers have studied the effectiveness of general, rather than specific ones for anxiety disorders. These new treatments target core factors thought to maintain anxiety disorders in general.

It struck me how much this fits into my work as a primary care physician.

The three major diseases I deal with on a daily basis, type 2 diabetes, cardiovascular disease, and obesity really respond to the same dietary and lifestyle interventions (low carb, high good fat, moderate exercise), and now we even have drugs with transdiagnostic benefits: jardiance (empagliflocin), an SGLT2 inhibitor, makes you excrete more sugar in the urine (like one of my recent patients did on her own) and also happens to lower the risk of cardiovascular death by 38 percent.

Another example of transdiagnostic therapies in primary care is the fact that SSRI antidepressants are now first-line treatment for anxiety, depression and irritable bowel syndrome. I am not smart enough to know where IBS ends and anxiety begins, but I do believe they are not one and the same.

Fibromyalgia and other neuropathic pain syndromes like postherpetic neuralgia and sciatica respond to SNRI antidepressants (duloxetine), which are also obviously useful tools in depression treatment.

Metformin is another example of a transdiagnostic medication treatment, used for diabetes and polycystic ovary syndrome, conditions that have similarities but also several differences.

This brings me back to the notion I was introduced to in medical school:

Be familiar with many medications, but develop expert, in-depth knowledge about the use of a few select ones with particular efficacy or breadth.

My new word reminded me of that.

And when it comes to the two dozen subtypes of anxiety, that just reminds me of the absurdity of ICD-10 codes, like “accidental drowning and submersion due to fall in (into) bathtub (W16.211).”

Drowning is pretty much drowning. And I refuse to believe that there is any practical need to have 25 different types of anxiety.

ADVERTISEMENT

Transdiagnostic treatments eliminate the need for obsessive-compulsive diagnosticism.

“A Country Doctor” is a family physician who blogs at A Country Doctor Writes:.

Image credit: Shutterstock.com

Prev

Be the honest doctor instead of the confident one

October 30, 2018 Kevin 3
…
Next

A story about the Patient and the Big Man

October 30, 2018 Kevin 0
…

Tagged as: Primary Care, Rheumatology

Post navigation

< Previous Post
Be the honest doctor instead of the confident one
Next Post >
A story about the Patient and the Big Man

ADVERTISEMENT

More by Hans Duvefelt, MD

  • The art of asking where it hurts

    Hans Duvefelt, MD
  • Thinking like a plumber when adjusting medications

    Hans Duvefelt, MD
  • The American food conspiracy

    Hans Duvefelt, MD

Related Posts

  • Primary Care First: CMS develops a value-based primary care program for independent practices

    Robert Colton, MD
  • How the CPT system shortchanges primary care

    Richard Young, MD
  • Primary care makes a difference for patients and the nation

    Glen R. Stream, MD
  • The many benefits of strengthening the primary care workforce

    Nicole Liner-Jigamian, MSW
  • Primary care faces a very difficult winter

    Ken Terry
  • The biggest health care fix: a relentless focus on primary care

    Suneel Dhand, MD

More in Conditions

  • Is white coat hypertension harmless?

    Monzur Morshed, MD and Kaysan Morshed
  • Gen Z, ADHD, and divided attention in therapy

    Ronke Lawal
  • Early-onset breast cancer: a survivor’s story

    Sara Rands
  • Remote second opinions for equitable cancer care

    Yousuf Zafar, MD
  • Why psychiatrists can’t treat family members

    Farid Sabet-Sharghi, MD
  • Aging parents and Thanksgiving: a gentle check-in

    Barbara Sparacino, MD
  • Most Popular

  • Past Week

    • Is white coat hypertension harmless?

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • A new autism care model in Idaho

      Ronald L. Lindsay, MD | Conditions
    • Protecting elder clinicians from violence

      Gerald Kuo | Conditions
    • China’s health care model of scale and speed

      Myriam Diabangouaya, MD & Vikram Madireddy, MD | Physician
    • The myth of endless availability in medicine

      Emmanuel Chilengwe | Conditions
    • Bureaucratic evil in modern health care

      Dr. Bryan Theunissen | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
  • Recent Posts

    • Is white coat hypertension harmless?

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • How to fight for your loved one during a medical crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Is trauma surgery a dying field?

      Farshad Farnejad, MD | Physician
    • Gen Z, ADHD, and divided attention in therapy

      Ronke Lawal | Conditions
    • Innovation in medicine: 6 strategies for docs

      Jalene Jacob, MD, MBA | Tech
    • Why we fund unproven autism therapies

      Ronald L. Lindsay, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Is white coat hypertension harmless?

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • A new autism care model in Idaho

      Ronald L. Lindsay, MD | Conditions
    • Protecting elder clinicians from violence

      Gerald Kuo | Conditions
    • China’s health care model of scale and speed

      Myriam Diabangouaya, MD & Vikram Madireddy, MD | Physician
    • The myth of endless availability in medicine

      Emmanuel Chilengwe | Conditions
    • Bureaucratic evil in modern health care

      Dr. Bryan Theunissen | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
  • Recent Posts

    • Is white coat hypertension harmless?

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • How to fight for your loved one during a medical crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Is trauma surgery a dying field?

      Farshad Farnejad, MD | Physician
    • Gen Z, ADHD, and divided attention in therapy

      Ronke Lawal | Conditions
    • Innovation in medicine: 6 strategies for docs

      Jalene Jacob, MD, MBA | Tech
    • Why we fund unproven autism therapies

      Ronald L. Lindsay, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...